192 related articles for article (PubMed ID: 9114136)
1. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents.
Rosenthal SL; Stanberry LR; Biro FM; Slaoui M; Francotte M; Koutsoukos M; Hayes M; Bernstein DI
Clin Infect Dis; 1997 Feb; 24(2):135-9. PubMed ID: 9114136
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls.
Stanberry LR; Rosenthal SL; Mills L; Succop PA; Biro FM; Morrow RA; Bernstein DI
Clin Infect Dis; 2004 Nov; 39(10):1433-8. PubMed ID: 15546077
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to herpes simplex virus types 1 and 2, Epstein-Barr virus and cytomegalovirus in teenage girls.
Andersson-Ellström A; Svennerholm B; Forssman L
Scand J Infect Dis; 1995; 27(4):315-8. PubMed ID: 8658062
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.
Wutzler P; Doerr HW; Färber I; Eichhorn U; Helbig B; Sauerbrei A; Brandstädt A; Rabenau HF
J Med Virol; 2000 Jun; 61(2):201-7. PubMed ID: 10797375
[TBL] [Abstract][Full Text] [Related]
6. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
Austin H; Macaluso M; Nahmias A; Lee FK; Kelaghan J; Fleenor M; Hook EW
Sex Transm Dis; 1999 Jul; 26(6):329-34. PubMed ID: 10417020
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.
Roest RW; van der Meijden WI; van Dijk G; Groen J; Mulder PG; Verjans GM; Osterhaus AD
Int J Epidemiol; 2001 Jun; 30(3):580-8. PubMed ID: 11416087
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.
Rabenau HF; Buxbaum S; Preiser W; Weber B; Doerr HW
Med Microbiol Immunol; 2002 Mar; 190(4):153-60. PubMed ID: 12005327
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
Bradley H; Markowitz LE; Gibson T; McQuillan GM
J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
[TBL] [Abstract][Full Text] [Related]
10. Detection of cytomegalovirus, human parvovirus B19, and herpes simplex virus-1/2 in women with first-trimester spontaneous abortions.
Zhou Y; Bian G; Zhou Q; Gao Z; Liao P; Liu Y; He M
J Med Virol; 2015 Oct; 87(10):1749-53. PubMed ID: 25976377
[TBL] [Abstract][Full Text] [Related]
11. Infection status of human parvovirus B19, cytomegalovirus and herpes simplex Virus-1/2 in women with first-trimester spontaneous abortions in Chongqing, China.
Gao YL; Gao Z; He M; Liao P
Virol J; 2018 Apr; 15(1):74. PubMed ID: 29688863
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.
Woestenberg PJ; Tjhie JH; de Melker HE; van der Klis FR; van Bergen JE; van der Sande MA; van Benthem BH
BMC Infect Dis; 2016 Aug; 16():364. PubMed ID: 27484304
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.
Marrazzo JM; Stine K; Wald A
Sex Transm Dis; 2003 Dec; 30(12):890-5. PubMed ID: 14646636
[TBL] [Abstract][Full Text] [Related]
15. Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents.
Sucato G; Celum C; Dithmer D; Ashley R; Wald A
Pediatr Infect Dis J; 2001 Apr; 20(4):422-6. PubMed ID: 11332668
[TBL] [Abstract][Full Text] [Related]
16. Serological evidence of herpesvirus infection in gibbons.
Sakulwira K; Theamboonlers A; Charoonrut P; Ratanakorn P; Poovorawan Y
BMC Microbiol; 2002 May; 2():11. PubMed ID: 12038968
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of herpes simplex virus infections in adolescent women.
Fife KH; Fortenberry JD; Ofner S; Katz BP; Morrow RA; Orr DP
Sex Transm Dis; 2006 Jul; 33(7):441-4. PubMed ID: 16540882
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan.
Abuharfeil N; Meqdam MM
New Microbiol; 2000 Jul; 23(3):235-9. PubMed ID: 10939038
[TBL] [Abstract][Full Text] [Related]
20. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
